Ekström, Kathrine
Jensen, Maria Radu Juul
Holmvang, Lene
Joshi, Francis Richard
Iversen, Allan Zeeberg
Madsen, Per Lav
Olsen, Niels Thue
Pedersen, Frants
Sørensen, Rikke
Tilsted, Hans-Henrik
Engstrøm, Thomas
Lønborg, Jacob
Funding for this research was provided by:
Copenhagen University
Article History
Received: 3 August 2023
Accepted: 3 November 2023
First Online: 21 December 2023
Declarations
:
: Dr. Engstrøm reports personal fees from Abbott, Bayer, and AstraZeneca outside the submitted work. Dr. Radu Juul Jensen reports personal fees from Abbott and Novo Nordisk outside the submitted work. Dr. Joshi reports personal fees from Boston Scientific and Abbott outside of the submitted work. Dr. Olsen reports institutional research support from Abbott. Dr. Ekström and Dr. Radu Juul Jensen were employed at Novo Nordisk A/S after the study was completed. The remaining authors declare no conflicts of interest.